Form D — Caradon Therapeutics, Inc.
0002108983-26-000001 · filed 2026-02-03
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $900,000
- Total sold
- $559,328
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Caradon Therapeutics, Inc.
- CIK
- 2108983
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 1281 HYMETTUS AVE.
ENCINITAS, CA 92024 - Phone
- (619) 990-0290
Related persons
-
Brian Laurence Johnson · Executive OfficerEncinitas, CA
View original on SEC EDGAR.